Latest Market News

James Hardie confirms key board changes and underscores its commitment to shareholder value amid strong integration progress with AZEK.

Althea Group Holdings reported a resilient September quarter with $5.4 million in receipts despite a major strike in British Columbia, bolstered by a $2.53 million capital raise and expansion in the US THC beverage market.

Eden Innovations reports solid Q1 FY2026 sales growth with expanding EdenCrete® and OptiBlend® markets, alongside key US property sale developments aimed at debt reduction.

Impact Minerals Limited reported a net cash outflow in operating and investing activities for Q3 2025 but strengthened its cash position through a significant equity raise, ending the quarter with nearly $5 million in cash.

Lake Resources applauds Lilac Solutions’ launch of its fifth-generation ion exchange technology, promising significant cost and efficiency gains for the Kachi lithium project.

Southern Palladium has cleared major regulatory hurdles and confirmed robust economics for its Bengwenyama platinum group metals project, supported by a $20 million capital raise to fund next-stage development.

Firebrick Pharma is set to expand its Nasodine product line with the launch of a new throat spray, targeting export markets starting November 2025, beginning with Singapore.

Anax Metals has made significant progress on its Whim Creek Copper-Zinc project, securing a waste rock processing agreement and continuing efforts to finalize project financing.

Western Mines Group has successfully extended a high-grade nickel sulphide zone at its Mulga Tank project in Western Australia through diamond drilling, confirming a robust mineral system with promising parallels to the Perseverance deposit.

Felix Gold has revealed two new massive surface stibnite discoveries at its Treasure Creek project in Alaska, significantly expanding the known high-grade antimony mineralisation. These findings, alongside robust drilling results, reinforce the project's potential to address critical US supply shortages amid global market disruptions.

CONNEQT Health reports robust 50% quarter-on-quarter growth in Pulse device sales and launches a new pricing strategy to boost recurring revenue. The company also secures a significant US clinical trial contract and advances cost-cutting efforts.

D3 Energy has secured formal acceptance of its Production Right Application for the ER315 permit in South Africa, marking a pivotal step toward production. The company also broadened its portfolio with new helium and hydrogen permits in Australia and began trading on the US OTCQX market.